David H Sherman

This inventor holds 24 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: University of Michigan, Regents of the University of Minnesota, Colorado State University Research Foundation. Active years: 2001-2026.

USPTO Granted Patents = 24 (Patent Applications = 3)

% Patents Active = 87.5

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 22(Granted Patents)

Location History:

St. Louis Park, MN (US) (2001 - 2003)
Ann Arbor, MI (US) (2007 - 2023)

Company Filing History:

18 out of 3,519

University of Michigan

patents

6 out of 2,364

Regents of the University of Minnesota

patents

3 out of 488

Colorado State University Research Foundation

patents

4. 2 out of 88

Allegheny-Singer Research Institute

patents

5. 1 out of 1

Asociacion Instituto Nacional De Biodiversidad

Inha-Industry Partnership Institute

patents

8. 1 out of 644

Rensselaer Polytechnic Institute

patents

9. 1 out of 15,977

University of California

patents

where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12594258 - Inhibitors of MHC-I Nef downmodulation for treating HIV (2026-04-07),

2. 12252714 - Halogenation of complex organic compounds (2025-03-18),

3. 11692176 - Halogenation of complex organic compounds (2023-07-04),

4. 11530204 - Biocatalytic synthesis of cryptophycin anticancer agents (2022-12-20),

5. 11008553 - Halogenation of complex organic compounds (2021-05-18),

6. 10239918 - Cahuitamycins and methods of making and using the same (2019-03-26),

7. 9994885 - Nonribosomal peptide synthetases (2018-06-12),

8. 9803187 - Baulamycins, compositions and methods of use thereof (2017-10-31),

9. 9650656 - Biosynthetic systems producing fungal indole alkaloids (2017-05-16),

10. 9611491 - Biosynthetic pathway for heterologous expression of a nonribosomal peptide synthetase drug and analogs (2017-04-04),

11. 9605015 - Polyene compound, method for preparing the same, and antifungal drug comprising novel polyene compound as active ingredient (2017-03-28),

12. 9487763 - Nonribosomal peptide synthetases (2016-11-08),

13. 8815562 - Biosynthetic pathway for heterologous expression of a nonribosomal peptide synthetase drug and analogs (2014-08-26),

14. 8765431 - Method for enzymatic production of decarboxylated polyketides and fatty acids (2014-07-01),

15. 8313936 - Nucleic acids and polypeptides involved in the production of cryptophycin (2012-11-20),

Title: The Innovative Journey of David H Sherman

Introduction: David H Sherman, a distinguished inventor based in Ann Arbor, MI, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: David H Sherman holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With over two decades of experience in the industry, David has worked with leading tech companies and research institutions, spearheading projects that have revolutionized various sectors.

Collaborations: Throughout his career, David has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and excellence in all his projects.

Conclusion: David H Sherman's relentless pursuit of innovation and his passion for creating cutting-edge solutions have solidified his reputation as a visionary inventor in the technological landscape.